The digital transformation of healthcare in India is gaining momentum, and video consultations for diabetes are at the forefront of this shift. Recent longitudinal research investigated the experiences of Type 1 diabetes patients on insulin pump therapy and their healthcare providers. This study offers valuable insights into how clinicians can optimize remote interactions while maintaining high standards of care. As telemedicine becomes a staple in chronic disease management, understanding the balance between convenience and clinical thoroughness is essential.

Clinical Utility of Video Consultations for Diabetes

One of the primary advantages of video-based care is its ability to minimize disruption to a patient's routine. Notably, patients reported that the technology allowed them to stay in their "everyday life" while still receiving expert guidance. For minor issues or small treatment adjustments, video calls were viewed as efficient and sufficient. Consequently, this model of care is particularly beneficial for stable patients who require frequent but short check-ins. Furthermore, the synchronous nature of video allows for real-time visual confirmation of injection sites or pump settings, which is a significant upgrade over traditional phone calls.

Addressing the Preparation Burden

However, the transition to virtual care is not without hurdles. Many healthcare professionals and patients noted that the fear of missing physical clinical signs remains a significant concern. Furthermore, the extensive pre-visit preparation required for insulin pump users—such as uploading sensor and pump data—can be taxing. Therefore, clinicians must emphasize the importance of data sharing before the call to ensure the session is productive. If carried out correctly, these consultations can significantly empower patients and improve overall treatment satisfaction. Notably, the study found that while video is excellent for minor issues, it may be perceived as less effective for complex medical crises.

Best Practices for Remote Pump Management

To ensure success, clinicians should categorize visits based on complexity. For instance, initial pump starts or complex metabolic crises may still necessitate in-person evaluation to ensure safety. In contrast, routine dose titrations are ideal for the video format. By providing clear requirements and guidance on preparation, providers can overcome the common obstacles identified in research. Ultimately, video consultations represent a versatile tool that sits somewhere between a phone call and an in-person visit, requiring adjusted clinical workflows to be fully effective.

Frequently Asked Questions

Which patients are best suited for video consultations?

Patients with stable Type 1 diabetes who are comfortable with technology and have demonstrated consistent data-sharing habits are ideal candidates. Video is particularly useful for routine follow-ups and minor dosage adjustments.

What data should be prepared before a remote diabetes visit?

Patients should upload their insulin pump and continuous glucose monitor (CGM) data at least 24 hours before the appointment. This allows the clinician to review trends and prepare specific recommendations in advance.

Can video consultations replace all in-person visits for pump users?

While video is highly effective for many aspects of care, periodic in-person visits remain necessary for comprehensive physical examinations, site inspections, and addressing complex psychological or medical issues.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Schultz ANØ et al. Diabetes care through video consultations: Insights from people using insulin pump therapy and healthcare professionals-A longitudinal qualitative study. Diabet Med. 2026 May 26. doi: 10.1111/dme.70319. PMID: 42192200.

Ghosh A, Gupta R, Misra A. Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: guidelines for physicians. Diabetes Metab Syndr. 2020;14(4):714-715.

Jothydev K, et al. Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy. J Diabetes Sci Technol. 2011;5(2):290-297.